Estimated antiretroviral therapy coverage among people living with HIV in Egypt
Egypt: Estimated antiretroviral therapy coverage among people living with HIV was 48.0% in 2025. ◆ Volatile
Estimated antiretroviral therapy coverage among people living with HIV in Egypt, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, estimated antiretroviral therapy coverage among people living with hiv in Egypt stood at 48.0%. That is the highest value across all 26 years on record.
That represents a change of up 9.1% on the previous year and up 500.0% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among people living with hiv in Egypt peaked at 48.0% in 2025 and was at its lowest, 0.0%, in 2000.
Egypt ranks 127th of 143 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Estimated antiretroviral therapy coverage among people living with HIV in Egypt, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 1.0% | — |
| 2007 | 1.0% | +0.0% |
| 2008 | 2.0% | +100.0% |
| 2009 | 2.0% | +0.0% |
| 2010 | 3.0% | +50.0% |
| 2011 | 3.0% | +0.0% |
| 2012 | 4.0% | +33.3% |
| 2013 | 5.0% | +25.0% |
| 2014 | 7.0% | +40.0% |
| 2015 | 8.0% | +14.3% |
| 2016 | 11.0% | +37.5% |
| 2017 | 15.0% | +36.4% |
| 2018 | 19.0% | +26.7% |
| 2019 | 22.0% | +15.8% |
| 2020 | 26.0% | +18.2% |
| 2021 | 28.0% | +7.7% |
| 2022 | 34.0% | +21.4% |
| 2023 | 37.0% | +8.8% |
| 2024 | 44.0% | +18.9% |
| 2025 | 48.0% | +9.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.6% | 0.0% | 2.0% | 10 |
| 2010s | 9.7% | 3.0% | 22.0% | 10 |
| 2020s | 36.2% | 26.0% | 48.0% | 6 |
Countries ranked near Egypt
- 126 Bolivia, Plurinational State of 51.0% compare
- 127 Indonesia 48.0% compare
- 129 Belize 47.0% compare
- 130 Saint Lucia 46.0% compare
More health data for Egypt
- Un projection of annual infant deaths, annual growth rate -1.46 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7884 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 946 deaths per 1,000 people (2090)
- Number of infants who die before age 1 7,225 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.3993 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0487 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.4524 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among people living with hiv in Egypt?
- Estimated antiretroviral therapy coverage among people living with hiv in Egypt was 48.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among people living with hiv recorded in Egypt?
- The highest recorded value was 48.0% in 2025.
- What is the lowest estimated antiretroviral therapy coverage among people living with hiv recorded in Egypt?
- The lowest recorded value was 0.0% in 2000.
- How does Egypt rank for estimated antiretroviral therapy coverage among people living with hiv?
- Egypt ranks 127th out of 143 countries with data for 2025.
- Is estimated antiretroviral therapy coverage among people living with hiv rising or falling in Egypt?
- Over the last ten years it is up 500.0%. The long-run trend across the full record is volatile.
- Where does this Egypt data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).